Epredia invests in Aiforia, a software company providing AI-based solutions for clinical and preclinical image analysis in pathology. The size of the Series B financing round is €12.6M with the potential to reach €25.2M if investors exercise the optional second tranche.

Epredia is a global leader in the anatomical pathology field, providing comprehensive solutions for precision cancer diagnostics and tissue diagnostics. The funding round is led by Epredia’s UK entity, a subsidiary of PHC Holdings Corporation.

Read more on Aiforia´s website.